Federal Register / Vol. 85, No. 237 / Wednesday, December 9, 2020 / Notices 79219 

Specifically, ANSYS, Inc., Canonsburg, 

PA, has been added as a party to this 

venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and EVESE 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On September 24, 2020, EVESE filed 

its original notification pursuant to 

Section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to Section 

6(b) of the Act on October 15, 2020 (85 

FR 65423). 

The last notification was filed with 

the Department on October 20, 2020. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on November 19, 2020 (85 FR 

73750). 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2020–26975 Filed 12–8–20; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to The National 

Cooperative Research and Production 

Act of 1993—Medical Technology 

Enterprise Consortium 

Notice is hereby given that, on 

November 18, 2020, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

Medical Technology Enterprise 

Consortium (‘‘MTEC’’) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Abram Scientific, Inc., 

Menlo Park, CA; Accenture Federal 

Services, Arlington, VA; Ace 

Laboratories Inc., Yarrow Point, WA; 

Aceso Plasma, Virginia Beach, VA; ACF 

Technologies, Inc, Asheville, NC; 

Action Medical Technologies LLC, 

Conshohocken, PA; Acuity Systems, 

LLC, Herndon, VA; Aerpio 

Pharmaceuticals, Cincinnati, OH; 

AirStrip Technologies, San Antonio, 

TX; Airway Medical Innovations Pty 

Ltd, Brisbane Queensland, AUS; 

Aktivax, Inc., Broomfield, CO; Allvivo 

Vascular, Inc., Lake Forest, CA; 

Altimmune, Inc., Gaithersburg, MD; 

Amydis, Inc., San Diego, CA; Aptahem 

AB, Malmo, SWE; Aptive Resources, 

LLC, Alexandria, VA; ARD Global LLC, 

McLean, VA; Articulate Labs, Dallas, 

TX; Ashvattha Therapeutics, Inc, 

Redwood City, CA; Astrocyte 

Pharmaceuticals Inc., Cambridge, MA; 

Asymmetric Technologies, LLC, 

Columbus, OH; Athena GTX, Johnston, 

IA; Atomo, Inc, West Lake Hills, TX; 

Augusta University Resarch lnstitute, 

Inc., Augusta, GA; Augustine 

Consulting, Inc. (ACI), Monterrey, CA; 

Auxocell Laboratories, Inc, Cambridge, 

MA; Avera Health, Sioux Falls, SD; 

Bambu Vault, LLC, Lowell, MA; Berry 

Consultants, LLC, Austin, TX; Beyond 

Barriers Therapeutics, Inc., Glencoe, IL; 

Bioflight, LLC, Akron, OH; 

BioGenerator, Saint Louis, MO; Biotags 

LLC, Key Biscayne, FL; Blue Cirrus 

Consulting LLC, Greenville, SC; Board 

of Trustees of the University of Illinois, 

Champaign, IL; Brainbox Solutions Inc., 

Richmond, VA; CAPRICOR 

THERAPEUTICS, INC., Beverly, CA; 

Carahsoft Technology Corporation, 

Reston, VA; Centivax, Inc., South San 

Francisco; Ceras Health Inc., New York, 

NY; Channel Clinical Solutions, LLC, 

Raleigh, NC; Chenega Reliable Services, 

LLC, San Antonio, TX; Cherish Health, 

Inc., Cambridge, MA; Clarkson 

University, Potsdam, NY; Coalition for 

National Trauma Research, San 

Antonio, TX; Computer Technology 

Associates, Inc., Ridgecrest, CA; Conflict 

Kinetics Corporation, Sterling, VA; Core 

Mobile Networks Inc.; DBA Core Mobile 

Inc., Campbell, CA; Crimson 

Government LLC, Carlisle, OH; Curza 

Global, LLC, Salt Lake City, UT; Data 

Intelligence Technologies, Inc., 

Arlington, VA; DEFTEC Corporation, 

Huntsville, AL; Digital For Mental 

Health (MYNDBLUE), Paris, FRA; 

Diomics Corporation, Murrietta, CA; 

DocBox Inc., Waltham, MA; EchoNous 

Inc., Redmond, WA; ECI Defense Group, 

Lyles, TN; Empatica, Inc., Boston, MA; 

Endomedix Inc., Montclair, NJ; 

Etiometry Inc., Boston, MA; Eumentis 

Therapeutics Inc, Newton, MA; Exciton 

Technologies Inc., Edmonton, Alberta, 

CAN; Expesicor Inc., Missoula, MT; 

FesariusTherapeutics Inc., Brooklyn, 

NY; FHI Clinical Inc., Durham, NC, 

Fitbit, Inc., San Franciso, CA; Flashback 

Technologies, Inc., Louisville, CO; 

FloTBI Inc., Cleveland, OH; FUJIFILM 

Pharmaceuticals USA, Inc., Valhalla, 

NY; GelMEDIX Inc., Newton, MA; 

GeneCapture, Inc., Huntsville, AL; 

General Biologics Inc., Cambridge, MA; 

Get Help Now LLC, Fort Myers, FL; 

GreyScan Inc., Melbourne, FL; Heat 

Biologics, Morrisville, NC; Hememics 

Biotechnologies Inc, Gaithersburg, MD; 

Hough Ear Institute, Oklahoma City, 

OK; Humanetics Corporation, Edina, 

MN; Hybrid Plastics Inc., Hattiesburg, 

MS; Iacta Pharmaceuticals Inc, Irvine, 

CA; Ichor Sciences, LLC, Nashville, TN; 

ImmunoVation, LLC, Pasadena, CA; 

INCELL Corporation LLC, San Antonio, 

TX; Infectious Disease Research 

Institute, Seattle, WA; Inflammatory 

Response Research Inc., Santa Barbara, 

CA; Informa Business Intelligence Inc., 

New York, NY; Inhalon Biopharma, Inc., 

Durham, NC; Innovenn, Inc., Madison, 

WI; Innsightful, Inc., Sunnyvale, CA; 

Integrated Computer Solutions, Inc., 

Waltham, MA; InTouch Technologies, 

D/B/A Inc. InTouch Health, Goleta, CA; 

J.R. Reingold & Associates, Inc, 

Alexandria, VA; JTEK Data Solutions, 

LLC, Bethesda, MD; KMASS 

SOLUTIONS, El Paso, TX; Knowmadics, 

Inc., Herndon, VA; Level Ex, Inc., 

Chicago, IL; LifeQ, Inc, Alphaertta, GA; 

LMI Consulting, LLC, Tysons, VA; 

LOGGEREX INC., Deland, FL; Lumen 

Bioscience, Inc., Seattle, WA; Luna 

Innovations Incorporated, Roanoke, VA; 

MadApparel Ind. DBA Athos, Redwood 

City, CA; ManTech Advanced Systems 

International, Inc., Herndon, VA; Mantel 

Technologies Inc., Fort Collins, CO; 

Masimo Corporation, Irvine, CA; 

Materials Modification Inc., Fairfax, VA; 

Medcura, Inc., Riverdale, MD; Media 

Riders Inc., Pearland, TX; Medical 

Center of the Americas Foundation, El 

Paso, TX; Medicortex Finland Oy, 

Turku, FIN; Medtrade Products Limited, 

Crew, Cheshire, GBR; MEMBIO INC., 

Kitchener, CAN; Mespere LifeSciences 

Inc., Waterloo, Ontario, CAN; 

MicroHealth, LLC, Vienna, VA; 

Microsoft, Redmon, VA; Millennium 

Enterprise Corporation, Fairfax, VA; 

Mineurva LLC, Albuquerque, NM; 

Moberg Analytics Inc., Ambler, PA; 

Moleculin Biotech, Inc., Houston, TX; 

Nanowear Inc., New York, NY; 

Neuronasal Inc, Wexford, PA; 

Neuronoff, Inc., Valencia, CA; New 

Horizons Diagnostics Corporation, 

Baltimore, MD; New Jersey Institute of 

Technology, Newark, NJ; NoMo 

Diagnostics, Chicago, IL; Non-Invasive 

Medical Systems LLC, Stamford, CT; 

North Carolina State University, 

Raleigh, NC; Northwestern University, 

Evanson, IL; Nostromo, LLC, 

Kennebunk, ME; Nuada Orthopedics, 

Inc., Sherborn, MA; Nyrada Inc., 

Gordon, AUS; Obatala Sciences, Inc., 

New Orleans, LA; Oculogica, Inc., New 

York, NY; Odin Technologies, Chicago, 

IL; OLGS Inc., Imperial, PA; Oregon 

Health & Science University, Portland, 

OR; Otolith Labs, Washington, DC; 


jbell on DSKJLSW7X2PROD with NOTICES
79220 Federal Register / Vol. 85, No. 237 / Wednesday, December 9, 2020 / Notices 

Panakeia LLC, Newport News, VA; 

Parnell Pharmaceuticals Inc., San 

Rafael, CA; Patchd, Inc., San Francisco, 

CA; Perspecta Enterprise Solutions LLC, 

Herndon, VA; Pinteon Therapeutics, 

Newton Center, MA; Posit Science 

Corporation, San Francisco, CA; PPD 

Development LP, Wilmington, NC; 

Predictions Systems Inc., Spring Lake, 

NJ; Promaxo, Oakland, CA; QUASAR 

Federal Systems, Inc., San Diego, CA; 

REACT Neuro, Cambridge, MA; Remote 

Health LLC, Springfield, OH; Renovo 

Concepts, Inc., San Antonio, TX; 

Rensselaer Polytechnic Institute, Troy, 

NY; Research Bridge Partners, Inc., 

Austin, TX; Resolys Bio, Inc., Delanson, 

NY; RIVA Solutions, Inc., McLean, VA; 

RTI International, Research Triangle 

Park; SAIC, Reston, VA; Sandstone 

Diagnostics, Inc., Pleasanton, CA; 

SaNOtize Research & Development 

Corp., Vancouver, CAN; Sense 

Diagnostics Inc., Cincinnati, OH; 

Sentien Biotechnologies, Lexington, 

MA; ServiceNow, Inc., Vienna, VA; 

Seventh Dimension, LLC, Mocksville, 

NC; Shipcom Federal Solutions, LLC, 

Belcamp, MD; Sibel Inc., Evanston, IL; 

Sierra Nevada Corporation (SNC), 

Sparks, NV; SightLife, Seattle, WA; Sim 

Vivo LLC, Essex, NY; SimX, Inc., 

Mountain View, CA; Snoretox Pty Ltd, 

Kew, Victoria, AUS; Softox Solutions 

AS, Oslo, NOR; STEL Technologies, 

LLC, Ann Arbor, MI; Stuart 

Therapeutics Inc, Stuart, FL; Symbinas 

Pharmaceuticals Inc., Jacksonville, FL; 

Systems Engineering Solutions 

Corporation, Greenbelt, MD; TechWerks 

LLC; Arlington Heights, IL; 

TeleCommunication Systems, Inc., 

Annapolis, MD; TensorX, Inc, Vienna, 

VA; Texas A&M University, College 

Station, TX; The Cleveland Clinic 

Foundation, Cleveland, OH; The 

Curators of the University of Missouri, 

on behalf of Missouri University of 

Science and Technology, Rolla, MO; 

The Research and Recognition Project 

Inc, Corning, NY; The Spaulding 

Rehabilitation Corporation, 

Charlestown, MA; The Spectrum Group, 

LLC, Alexandria, VA; The University of 

Alabama at Birmingham, Birmingham, 

AL; The University of Tennessee Health 

Science Center, Memphis, TN; The 

University of Texas at Dallas, 

Richardson, TX; Thornhill Reasearch 

Inc., North York, Ontario, CAN; 

Thornton Tomasetti, Inc., New York, 

NY; Tiber Creek Partners, Tiber Creek 

Partners, VA; Tissue Regeneration 

Sciences, Inc, Park City, UT; TITUS 

Sports Academy LLC, Tallahassee, FL; 

Tomorrow Lab LLC, New York, NY; 

Topadur Pharma AG, Schlieren, CHE; 

Trifecta Solutions, Reston, VA; Triton 

Systems Inc, Chelmsford, MA; Trustees 

of the University of Pennsylvania, 

Philadelphia, PA; UNandUP, LLC, Saint 

Louis, MO; Unissant, Inc., Herndon, VA; 

Universal Consulting Services, Inc., 

Fairfax, VA; University of Arizona 

Applied Research Corporation, Tucson, 

AZ; University of Georgia Research 

Foundation, Inc., Athens, GA; 

University of Kansas Medical Center 

Research Institute, Inc., Kansas City, KS; 

University of North Carolina at Chapel 

Hill, Chapel Hill, NC; University of 

Ottawa, Ottawa, CAN; University of 

South Carolina, Columbia, SC; 

University of South Florida, Tampa, FL; 

University of Southern California, Los 

Angeles, CA; Vinformatix LLC, Baton 

Rouge, LA; VIRGINIA HIGH 

PERFORMANCE LLC, Virginia Beach, 

VA; VirtuSense Technologies, Inc., 

Peoria, IL; Vista LifeSciences, Inc., 

Parker, CO; VXBIOSCIENCES, INC., 

Oakland, CA; Zane Networks, LLC, 

Washington, DC; ZOLL Medical 

Corporation, Chelmsford, MA; have 

been added as parties to this venture. 

Also, 21 MedTech, LLC, Burlington, 

NC; 410 Medical, Inc., Elgin, NC; 911 

Medical Devices, LLC, Houston, TX; 

98point6 Inc., Seattle, WA; Adventist 

Health System—Sunbelt, Inc. dba 

Florida Hospital, Orlando, FL; Akron 

Biotechnology, LLC, Boca Raton, FL; 

American Type Culture Collection 

(ATCC Federal Solutions), Manassas, 

VA; Arrevus, Inc., Raleigh, NC; 

Auckland UniServices Limited, 

Auckland, NZL; Awarables Inc., 

Baltimore, MD; Axonova Medical, LLC, 

Philadelphia, PA; Becton Dickinson & 

Company, Franklin Lake, NJ; Biobeat 

Technologies Ltd., Petach, Yikva, ISR; 

BioSpyder Technologies, Inc., Carlsbad, 

CA; Blood Systems, Inc. dba Blood 

Systems Research Institute, Scottsdale, 

AZ; bR3 UNIQ, Inc. dba QUADYSTER, 

Bettendorf, IA; Bramante Bioscience, 

Elmira Heights, NY; Brain Power, LLC, 

Cambridge, MA; Caci, Inc.—Federal, 

Chantilly, VA; Calimex USA 

Corporation, San Francisco, CA; Carmell 

Therapeutics Corporation, Pittsburgh, 

PA; Case Western Reserve University, 

Cleveland, OH; CFD Research 

Corporation, Huntsville, AL; Combat 

Medical Systems, Harrisburg, NC; 

Cortical Metrics, LLC, Semora, NC; 

Crius Technology Group, Austin, TX; 

Detact Diagnostics BV, Hoge der, 

Gronigen Netherlands; Droper Med 

America, LLC, Elgin, SC; Engility 

Corporation, Chantilly, VA; Existential 

Technologies, Inc., Chula Vista, CA; 

Family Health International DBA FHI 

360, Durham, NC; FloTBI, Cleveland, 

OH; FullSekurity Corporation, Irving, 

TX; Full Spectrum Omega, Inc., 

Huntington Beach, CA; Georgia Tech 

Research Corporation, Atlanta, GA; 

HeadsafelP Pty Ltd, Bronte, NSW, AUS; 

Healios, Inc., Flemington, NJ; 

Hemoclear B.V., Zwolle, Overijssel, 

Netherlands; Howmedica Osteonics 

Corp. dba Stryker Orthopaedics, 

Mahwah, NJ; Human Biomed, Inc., 

Siuth Burlington, VT; HYPR Life 

Sciences, Inc., Pilot Mountain, NC; 

ImmunoVation, LLC, Pasadena, CA; 

Integrum Scientific, LLC, Greensboro, 

NC; Irving Burton Associates, Inc. (IBA), 

Falls Church, VA; JumpStartCSR, 

Seattle, WA; Knowledge Driven LLC, 

Alexandria, VA; Kindred Biosciences, 

Inc., Burlingame, CA; Lieber Institute, 

Inc., Baltimore, MD; LongView 

International Technology Solutions, 

Inc., Herndon, VA; Magle Chemoswed 

AB, Lund, SWE; Massachusetts Eye and 

Ear Infirmary, Boston, MA; Melinta 

Therapeutics, Inc., New Haven, CT; 

MilanaPharm, LLC, Tallassee, AL; 

Molecular Biologicals, Pasadena, TX; 

MO–SCI Corporation, Rollo, MO; New 

Horizons Diagnostics Corporation, 

Baltimore, MD; New York University 

School of Medicine, New York, NY; 

Next Generation Stretcher Ltd, Raman 

gan, ISR; NON–INVASIVE MEDICAL 

SYSTEMS, LLC, Stamford, CT; NUES 

LLC, Silver Spring, MD; Onera Health 

Inc., Palo Alto, CA; PEER Technologies 

PLLC, Fairfax, VA; Phagelux (Canada) 

Inc., Montreal, CAN; Physcient, Inc., 

Durham, NC; Pluristem LTD, Haifa, ISR; 

PolarityTE MD, Inc., Salt Lake City, UT; 

Pop Test Oncology LLC aka Palisades 

Therapeutics, Cliffside Park, NJ; Power 

of Patients, LLC, Charleston, SC; 

Praeses, LLC, Shreveport, LA; Prep 

Tech, LLC, Westlake, LA; Pulmotect, 

Inc., Houston, TX; Q2Pharma, Haifa, 

ISR; Qrons, Inc., Miami, FL; Radical 

Concepts LLC, Brooklyn, NY; RegenFix, 

LLC, Toledo, OH; Remedor Biomed Ltd., 

Nazareth Illit, ISR; Roccor, LLC, 

Longmont, CO; San Diego Blood Bank, 

San Diego, CA; Scinus Cell Expansion 

B.V., Bilthoven, Utrecht; Seran 

Bioscience, Bend, OR; Sleep Care, Inc., 

Columbus, OH; SmartPoints 

Technology, Inc., Stow, MA; Southern 

Research Institute, Birmingham, AL; 

SurgiBox Inc., Brookline, MA; Syracuse 

University, Syracuse, NY; TBT Pharma, 

LLC, Baltimore, MD; TearSolutions, 

Inc., Charlottesville, VA; TerumoBCT, 

Inc., Lakewood, CO; TheraNova, LLC, 

San Francisco, CA; The University of 

Arizona, Defense and Security Research 

Institute (DSRI), Tucson, AZ; ThoraXS 

Israel 17 Ltd, Tzur Hadassa, ISR; 

Trailhead Biosystems Inc., Cleveland, 

OH; Truecath Inc., Camarillo, CA; 

Trustees of Boston University, Boston, 

MA; University of Florida Division of 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 237 / Wednesday, December 9, 2020 / Notices 79221 

Sponsored Programs, Gainesville, FL; 

University of South Carolina, Columbia, 

SC; University of Tartu, Tartu, EST; 

Upside Biotechnologies Ltd., Auckland, 

NZL; Virginia Polytechnic Institute and 

State University, Blacksburg, VA; Wello, 

Inc., Addison, TX; Williams-Jones 

Consulting, Greenville, SC; Worcester 

Polytechnic Institute, Worcester, MA; XTherma Inc., Richmond, CA; Yale 

University, New Haven, CT have 

withdrawn as parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and MTEC 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On May 9, 2014, MTEC filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 9, 2014 (79 FR 32999). 

The last notification was filed with 

the Department on October 17, 2019. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on November 12, 2019 (84 FR 

61071). 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2020–26978 Filed 12–8–20; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF LABOR 

Occupational Safety and Health 

Administration 

[Docket No. OSHA–2020–0003] 

Advisory Committee on Construction 

Safety and Health (ACCSH) 

AGENCY: Occupational Safety and Health 

Administration (OSHA), Labor. 

ACTION: Request for nominations for 

membership on ACCSH. 

SUMMARY: The Secretary of Labor 

requests nominations for membership 

on ACCSH. 

DATES: Submit (postmark, send, 

transmit) nominations for ACCSH 

membership by January 8, 2021. 

ADDRESSES: You may submit 

nominations and supporting materials 

by one of the following methods: 

Electronically: You may submit 

nominations, including attachments, 

electronically into Docket No. OSHA– 

2020–0003 at http://

www.regulations.gov, which is the 

Federal eRulemaking Portal. Follow the 

online instructions for submissions. 

Facsimile: If your nomination and 

supporting materials, including 

attachments, do not exceed 10 pages, 

you may fax them to the OSHA Docket 

Office at (202) 693–1648. 

Regular mail, express mail, hand 

delivery, or messenger (courier) service: 

Submit materials to the OSHA Docket 

Office, Docket No. OSHA–2020–0003, 

Room N–3653, U.S. Department of 

Labor, 200 Constitution Avenue NW, 

Washington, DC 20210; telephone: (202) 

693–2350. Please note: While OSHA’s 

Docket Office is continuing to accept 

and process requests, due to the 

COVID–19 pandemic, the Docket Office 

is closed to the public. 

Instructions: All nominations and 

supporting materials must include the 

agency name and docket number for this 

Federal Register document (Docket No. 

OSHA–2020–0003). Because of securityrelated procedures, submitting 

nominations by regular mail may result 

in a significant delay in their receipt. 

OSHA will post submissions in 

response to this Federal Register 

document, including personal 

information provided, without change at 

http://www.regulations.gov. Therefore, 

OSHA cautions interested parties about 

submitting personal information such as 

Social Security Numbers and birthdates. 

Access to docket: The http://

www.regulations.gov index lists all 

submissions provided in response to 

this Federal Register document; 

however, some information (e.g., 

copyrighted material) is not publicly 

available to read or download from that 

web page. All submissions, including 

materials not available online, are 

available for inspection through the 

OSHA Docket Office. For information 

about accessing materials in Docket No. 

OSHA–2020–0003, including materials 

not available online, contact the OSHA 

Docket Office. 

FOR FURTHER INFORMATION CONTACT: 

For press inquiries: Mr. Frank 

Meilinger, Director, OSHA Office of 

Communications; telephone: (202) 693– 

1999; email: meilinger.francis2@dol.gov. 

For general information about ACCSH 

and ACCSH membership: Mr. Damon 

Bonneau, OSHA, Directorate of 

Construction; telephone: (202) 693– 

2020; email: bonneau.damon@dol.gov. 

Copies of this Federal Register 

document: Electronic copies of this 

Federal Register document are available 

at http://www.regulations.gov. This 

document, as well as news releases and 

other relevant information are also 

available on the OSHA web page at 

http://www.osha.gov. 

SUPPLEMENTARY INFORMATION: The 

Secretary of Labor invites interested 

persons to submit nominations for 

membership on ACCSH. 

A. Background 

ACCSH advises the Secretary of Labor 

and the Assistant Secretary of Labor for 

Occupational Safety and Health 

(Assistant Secretary) in the formulation 

of standards affecting the construction 

industry, and on policy matters arising 

in the administration of the safety and 

health provisions under the Contract 

Work Hours and Safety Standards Act 

(Construction Safety Act (CSA)) (40 

U.S.C. 3701 et seq.) and the 

Occupational Safety and Health Act of 

1970 (OSH Act) (29 U.S.C. 651 et seq.) 

(see also 29 CFR 1911.10 and 1912.3). In 

addition, the OSH Act and CSA require 

the Assistant Secretary to consult with 

ACCSH before the agency proposes any 

occupational safety and health standard 

affecting construction activities (29 CFR 

1911.10; 40 U.S.C. 3704). 

ACCSH operates in accordance with 

the Federal Advisory Committee Act 

(FACA), as amended (5 U.S.C. App. 2), 

and the implementing regulations (41 

CFR 102–3 et seq.); and Department of 

Labor Manual Series Chapter 1–900 (8/ 

31/2020). ACCSH generally meets two 

to four times a year. 

B. ACCSH Membership 

ACCSH consists of 15 members whom 

the Secretary appoints. ACCSH 

members generally serve staggered twoyear terms, unless they resign, cease to 

be qualified, become unable to serve, or 

the Secretary removes them (29 CFR 

1912.3(e)). The Secretary may appoint 

ACCSH members to successive terms. 

No member of ACCSH, other than 

members who represent employers or 

employees, shall have an economic 

interest in any proposed rule that affects 

the construction industry (29 CFR 

1912.6). 

The categories of ACCSH 

membership, and the number of new 

members to be appointed to replace 

members whose terms will expire, are: 

• Five members who are qualified by 

experience and affiliation to present the 

viewpoint of employers in the 

construction industry—five employer 

representatives will be appointed; 

• Five members who are similarly 

qualified to present the viewpoint of 

employees in the construction 

industry—five employee representatives 

will be appointed; 

• Two representatives of State safety 

and health agencies—two 

representatives from a State safety and 

health agency will be appointed; 


jbell on DSKJLSW7X2PROD with NOTICES